Sila Realty Trust to Merge with Blue Owl Capital for $2.4 Billion
Sila Realty Trust's stock surged by 18.88% in pre-market trading, reaching a 52-week high.
The company has entered into a merger agreement with Blue Owl Capital, which will acquire all outstanding shares of Sila at $30.38 per share, valuing the transaction at approximately $2.4 billion. This deal represents a 19% premium over Sila's closing price on April 17, 2026, indicating strong market confidence in the transaction. CEO Michael A. Seton expressed that this merger reflects the company's commitment to shareholders and is expected to provide significant immediate benefits.
This merger is expected to solidify Sila's leadership in high-quality healthcare property investments, with Blue Owl's Marc Zahr highlighting the acquisition's potential to enhance their portfolio in the healthcare net lease sector, yielding stable cash flows and long-term growth potential.
Trade with 70% Backtested Accuracy
Analyst Views on SILA
About SILA
About the author

- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Select Medical Holdings Corporation's sale to a consortium led by executives at $16.50 per share, raising concerns about potential violations of shareholder rights and urging shareholders to understand their options.
- Merger Scrutiny: The merger of Envirotech Vehicles, Inc. with AZIO AI Corp. is also under investigation, with Halper Sadeh LLC encouraging Envirotech shareholders to reach out to learn about their legal rights, ensuring they are not overlooked during the merger process.
- Real Estate Transaction Review: The sale of Sila Realty Trust, Inc. to Blue Owl Real Estate Capital LLC for $30.38 per share is similarly scrutinized, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures to protect shareholder interests.
- Legal Fee Arrangement: Halper Sadeh LLC offers legal services on a contingency fee basis, meaning shareholders do not have to pay out-of-pocket legal fees when addressing these matters, ensuring all shareholders can defend their rights without financial burden.
- Shareholder Rights Protection: Monteverde & Associates is investigating the transaction between AvalonBay Communities, Inc. and Equity Residential, where AvalonBay shareholders are expected to receive 2.793 shares of Equity Residential common stock for each share held, impacting shareholder equity structure significantly.
- Merger Impact Analysis: Following the merger, Equity Residential shareholders will own approximately 48.8% of the combined entity, a shift that could alter market dynamics and influence investor strategies moving forward.
- Cash Acquisition Proposal: Shareholders of Select Medical Holdings Corporation are expected to receive $16.50 per share in cash, with a shareholder vote scheduled for June 26, 2026, providing immediate cash returns to investors and enhancing shareholder value.
- Real Estate Transaction Dynamics: Sila Realty Trust, Inc. shareholders are anticipated to receive $30.38 in cash per share, with voting also set for June 26, 2026, further driving consolidation and growth in the real estate market.

- Legal Investigation Launched: Halper Sadeh LLC is investigating Sila Realty Trust, Inc. (NYSE:SILA) regarding its sale to Blue Owl Real Estate Capital LLC at $30.38 per share, potentially infringing on shareholder rights, aiming to ensure fair treatment for investors.
- UniFirst Shareholder Rights Concern: UniFirst Corporation (NYSE:UNF) is being sold for $155.00 in cash and 0.7720 shares of Cintas stock per share, with Halper Sadeh LLC potentially advocating for higher transaction prices and additional disclosures to protect shareholder interests.
- Assertio Holdings Transaction Review: Assertio Holdings, Inc. (NASDAQ:ASRT) is selling to Garda Therapeutics for $18.00 per share in cash plus a contingent value right, and Halper Sadeh LLC is assessing whether this deal serves the best interests of shareholders, possibly seeking increased compensation.
- Kennedy-Wilson Transaction Risks: Kennedy-Wilson Holdings, Inc. (NYSE:KW) is being sold for $10.90 per share in cash to a consortium led by CEO William McMorrow, with Halper Sadeh LLC potentially representing shareholders to seek better terms and transparency to safeguard their investments.
- Investigation Focus: Halper Sadeh LLC is investigating Sila Realty Trust, Inc. (NYSE:SILA) for its sale to Blue Owl Real Estate Capital LLC at $30.38 per share, raising concerns about potential shareholder rights violations and encouraging shareholders to explore their options.
- Acquisition Terms: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) is being sold to Chiesi Group for $27.00 per share in cash, with Halper Sadeh LLC potentially seeking increased consideration to ensure fair compensation for shareholders.
- Transaction Options: Thermon Group Holdings, Inc. (NYSE:THR) is proposed to be sold to CECO Environmental Corp., offering shareholders a choice between cash and stock combinations or $63.89 per share in cash, with Halper Sadeh LLC advocating for better terms on behalf of shareholders.
- Legal Support: Lisata Therapeutics, Inc. (NASDAQ:LSTA) is selling to Kuva Labs, Inc. for $4.00 per share, and Halper Sadeh LLC provides no-cost legal consultations to help shareholders understand their rights and options, ensuring their legal interests are protected.
- KalVista Merger Investigation: KalVista Pharmaceuticals is set to be acquired by Chiesi Group for $27.00 per share, implying a total value of approximately $1.9 billion, with investigations focusing on whether the board breached fiduciary duties by failing to conduct a fair process.
- Thermon Acquisition Review: Thermon Group Holdings will be acquired by CECO Environmental in a deal valued at around $2.2 billion, allowing shareholders to choose between cash and stock, with investigations into potential breaches of fiduciary duties by the board regarding fair treatment of shareholders.
- Sila Realty Acquisition Inquiry: Sila Realty Trust is to be acquired by Blue Owl Capital for $30.38 per share, totaling approximately $2.4 billion, with investigations examining whether the board failed to ensure a fair process and fair value for shareholders.
- Lisata Therapeutics Merger Scrutiny: Lisata Therapeutics will be acquired by Kuva Labs for $4.00 per share plus contingent value rights, with investigations into whether the board breached fiduciary duties by not ensuring fair value in the transaction for shareholders.
- Quarterly Dividend Announcement: Sila Realty Trust declares a quarterly dividend of $0.40 per share, consistent with previous distributions, indicating the company's stable cash flow and shareholder return strategy, which is expected to bolster investor confidence.
- Dividend Yield: The forward yield of 5.23% makes this dividend attractive in the current market environment, potentially drawing in income-seeking investors and enhancing the company's competitive position within the Real Estate Investment Trust (REIT) sector.
- Financial Performance: Sila Realty Trust reports a GAAP EPS of $0.22 and revenue of $52.66 million, reflecting the company's ongoing growth potential in the high-yield healthcare real estate sector, despite facing AFFO headwinds, growth drivers are gradually aligning.
- Market Dynamics: The recent acquisition activities of Sila Realty Trust highlight that many REITs are still trading at a discount, potentially offering investors an opportunity to enter high-yield assets, further driving market interest in the company.










